Nexalin Technology Inc Revenue per Employee (NXL), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Nexalin Technology Inc   (NASDAQ: NXL)
 

Nexalin Technology Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Nexalin Technology Inc 's Revenue per employee fell on a trailing twelve month basis to $ 27,144, below the company average number of $44,387.
Within the Healthcare sector Employees of 518 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 3559, from total ranking in previous quarter at 4210. Nexalin Technology Inc has 8 employees.


What is Sales per Employee Ratio?







NXL Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change -82.77 % -63.55 % 532.46 % -49.63 % 163 %
Sales per Employee (TTM) $ 27,144 34,448 37,706 19,616 21,852
NXL's Total Ranking # 3559 # 4210 # 3747 # 3764 # 3811
Seq. Revenue Change -18.66 % -91.3 % 847.13 % -74.29 % 72.1 %


Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 171
Healthcare Sector # 519
Overall Market # 3559

Revenue per Employee Statistics
High Average Low
$ 165,170 $ 44,387 $ 13,844
(Dec 31 2022)   (Dec 31 2023)



Financial Statements
Nexalin Technology Inc 's Revenue MRQ $ 0 Millions Visit NXL's Income Statement
Nexalin Technology Inc 's Revenues TTM $ 0 Millions Visit NXL's aggregate revenue growth
What are NXL's Sales? Visit NXL's Sales by Segment




Other Ratios
Nexalin Technology Inc 's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NXL's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NXL's Competitors
Revenue per Employee for NXL's Suppliers
Revenue per Employee for NXL's Customers

You may also want to know
NXL's Sales Growth Rates NXL's Pe Price to earnings ratio NXL's Receivables Turnover Ratio NXL's Stock Quote
NXL's Net Income Growth Rates NXL's Ps Price to Sales ratio NXL's Sales per Employee NXL's Asset Turnover Ratio
NXL's Net Margin NXL's Pb Price to Book ratio NXL's Financial Strength Ratios NXL's Dividend Payout Ratio
Date modified: 2026-09-04T10:34:40+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Cg Oncology Inc   43,859.15 $ 6.228  Million 142 
Biocorrx Inc   43,701.83 $ 0.787  Million 18 
Vyne Therapeutics Inc   43,000.00 $ 0.430  Million 10 
Femasys Inc   42,581.67 $ 2.299  Million 54 
Upstream Bio Inc   42,106.67 $ 3.158  Million 75 
Sintx Technologies Inc   41,562.50 $ 1.330  Million 32 
Fate Therapeutics Inc   40,316.77 $ 6.491  Million 161 
Ocugen Inc   39,482.76 $ 4.580  Million 116 
Alumis inc   33,026.79 $ 7.398  Million 224 
Volitionrx Limited  32,773.92 $ 2.458  Million 75 
Longeveron Inc   31,236.84 $ 1.187  Million 38 
Entrada Therapeutics Inc   30,828.95 $ 4.686  Million 152 
Dbv Technologies S a   29,517.65 $ 5.018  Million 170 
Addus Homecare Corp  29,128.29 $ 1,475.610  Million 50,659 
Insight Molecular Diagnostics Inc   28,793.10 $ 1.670  Million 58 
Scientific Industries Inc   28,357.43 $ 5.728  Million 202 
Prime Medicine Inc   27,897.26 $ 4.073  Million 146 
Nexalin Technology Inc   27,144.38 $ 0.217  Million
Bioxcel Therapeutics Inc   25,586.21 $ 0.742  Million 29 
Bioadaptives Inc   25,561.00 $ 0.026  Million
Ataibeckley Inc   22,143.56 $ 4.473  Million 202 
Envoy Medical Inc   20,700.00 $ 0.207  Million 10 
Northwest Biotherapeutics Inc  20,695.24 $ 2.173  Million 105 
China Pharma Holdings Inc  17,710.83 $ 3.914  Million 221 
Cardiff Oncology Inc   16,387.10 $ 0.508  Million 31 
Mangoceuticals Inc   14,328.50 $ 0.315  Million 22 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.